| Lipids Management |
1 |
0.9 |
| Fatty Acids |
0 |
0.95 |
| Depression |
0 |
0.85 |
| Atrial Fibrillation |
0 |
0.58 |
| Cardiovascular Risk Management |
0 |
0.47 |
| Cardiometabolic Risk Factors |
0 |
0.41 |
| Anxiety Disorder |
0 |
0.32 |
| Heart Failure (HF) |
0 |
0.3 |
| Alzheimer Disease |
0 |
0.27 |
| Cerebrovascular Accident |
0 |
0.21 |
| Coronary Artery Disease (CAD) |
0 |
0.17 |
| Arrhythmia |
0 |
0.15 |
| Biliary Disease |
0 |
0.15 |
| Metabolic Syndrome |
0 |
0.15 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.15 |
| Cardiovascular disease |
0 |
0.14 |
| Corns |
0 |
0.14 |
| Myocardial Infarction (MI) |
0 |
0.12 |
| Patient Safety |
0 |
0.12 |
| Anxiety |
0 |
0.1 |
| Dentistry and Oral Health |
0 |
0.1 |
| Minerals |
0 |
0.1 |
| Rheumatoid Arthritis |
0 |
0.09 |
| Adverse Effects |
0 |
0.07 |
| Dementia |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Infarction |
0 |
0.07 |
| Liver Disease |
0 |
0.07 |
| ADHD |
0 |
0.06 |
| Asthma |
0 |
0.06 |
| Epilepsy |
0 |
0.06 |
| Menopause |
0 |
0.06 |
| Mild Cognitive Impairment |
0 |
0.06 |
| Type 2 Diabetes Mellitus |
0 |
0.06 |
| Cognitive Impairment |
0 |
0.05 |
| Fatty Liver |
0 |
0.05 |
| Alaska |
0 |
0.04 |
| Arthritis |
0 |
0.04 |
| Chemotherapy |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Concerns of Elderly |
0 |
0.04 |
| Dietary Supplements |
0 |
0.04 |
| Epidemiology |
0 |
0.04 |
| Fish Oil |
0 |
0.04 |
| Geriatrics |
0 |
0.04 |
| Hyperlipidemia |
0 |
0.04 |
| Impairment |
0 |
0.04 |
| Liver |
0 |
0.04 |
| Meta-Analysis |
0 |
0.04 |
| Periodontal Diseases |
0 |
0.04 |
| Premenstrual Syndrome |
0 |
0.04 |
| Tolerance |
0 |
0.04 |